![]() |
市場調查報告書
商品編碼
1375087
南美洲和中美洲心臟微導管市場預測至 2028 年 - COVID-19 影響和區域分析 - 按適應症(一般週邊血管和冠狀動脈)和最終用戶(醫院、專科診所和門診手術中心)South & Central America Cardiac Microcatheter Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Indication (General Peripheral Vascular and Coronary) and End User (Hospitals, Specialty Clinics, and Ambulatory Surgical Centers) |
南美洲和中美洲心臟微導管市場預計將從2023年的2,269萬美元成長到2028年的3,042萬美元。預計2023年至2028年的年複合成長率為6.0%。
擴大使用經皮冠狀動脈介入治療 (PCI) 來治療慢性完全阻塞 (CTO),推動南美洲和中美洲心臟微導管市場的成長
經皮冠狀動脈介入治療(PCI)是治療慢性完全阻塞(CTO)最困難的手術之一,需要成功達到CTO的再通。此外,CTO是一條或多根冠狀動脈的完全或接近完全阻塞。由於冠狀動脈內斑塊積聚,阻塞通常持續約三個月。過去十年來,隨著新穎產品的推出和批准,這一領域取得了重大進展。然而,隨著微導管被用作冠狀動脈介入工具,新技術設備的推出和策略改進仍在對抗 CTO 的程序中受到監控。該工具為複雜的冠狀動脈介入治療提供了一種治療方法,例如分叉病變、曲折的解剖結構、孔口位置、冠狀動脈鈣化、傾斜起飛和 CTO。 Terumo 的 FineCross MG 微導管整合了交叉能力和導絲支持,用於治療具有挑戰性的病例,包括彎曲血管、CTO、分叉以及嚴重狹窄和鈣化病變。因此,擴大使用 PCI 來治療 CTO,從而促進了心臟微導管市場的成長。
南美洲和中美洲心臟微導管市場概述
南美洲和中美洲心臟微導管市場分為阿根廷、巴西以及南美洲和中美洲其他地區。該地區在南美洲和中美洲心臟微導管市場中佔據重要地位,預計在預測期內將實現可觀的成長率。心血管疾病盛行率的增加、政府措施的增加以及該地區產品推出和批准的激增等促進因素正在加速南美洲和中美洲心臟微導管市場的成長。
南美洲及中美洲心臟微導管市場收入及 2028 年預測(百萬美元)
南美洲和中美洲心臟微導管市場細分
南美洲和中美洲心臟微導管市場分為適應症、最終用戶和國家。
根據適應症,南美洲和中美洲心臟微導管市場分為一般週邊血管和冠狀動脈。 2023 年,冠狀動脈細分市場在南美洲和中美洲心臟微導管市場中佔據更大佔有率。
根據最終用戶,南美洲和中美洲心臟微導管市場分為醫院、專科診所和門診手術中心。 2023 年,醫院細分市場在南美洲和中美洲心臟微導管市場中佔據最大佔有率。
根據國家/地區,南美洲和中美洲心臟微導管市場分為巴西、阿根廷以及南美洲和中美洲其他地區。 2023年,巴西在南美洲和中美洲心臟微導管市場佔有率中佔據主導地位。
波士頓科學公司;整數控股公司;美敦力公司;梅里特醫療系統公司;和 Teleflex Inc 是南美洲和中美洲心臟微導管市場的領先公司。
The South & Central America cardiac microcatheter market is expected to grow from US$ 22.69 million in 2023 to US$ 30.42 million by 2028. It is estimated to record a CAGR of 6.0% from 2023 to 2028.
Growing Use of Percutaneous Coronary Intervention (PCI) for Treating Chronic Total Occlusions (CTO) Fuels South & Central America Cardiac Microcatheter Market Growth
Percutaneous coronary intervention (PCI) is one of the most difficult procedures for treating of chronic total occlusions (CTO), resulting in successful recanalization of CTO. Further, CTO is complete or near-complete blockage of one or more coronary arteries. The blockage usually lasts approximately three months due to plaque build-up within a coronary artery. Significant progress has been made in this area over the past decade, given the novel product launches and approvals. However, the launch of new technical devices and strategic refinements are still being monitored in the procedures to combat CTOs as the microcatheters are used as a coronary interventional tool. This tool provides a therapeutic approach to complex coronary interventions such as bifurcation lesions, tortuous anatomy, ostial location, coronary calcification, angled takeoffs, and CTO. Terumo's FineCross MG microcatheter integrates cross ability and guidewire support for treating challenging cases including tortuous vessels, CTOs, bifurcations, as well as severely stenosed and calcified lesions. Therefore, the growing usage of PCIs for treating CTO is catalyzing the cardiac microcatheter market growth.
South & Central America Cardiac Microcatheter Market Overview
The South & Central America cardiac microcatheter market is segmented into Argentina, Brazil, and the Rest of South & Central America. The region occupies a significant position in the South & Central America cardiac microcatheter market and is expected to record a promising growth rate during the forecast period. Drivers such as increase in prevalence of cardiovascular disease, rise in government initiatives, and upsurge in launches and approvals of products in the region are accelerating the South & Central America cardiac microcatheter market growth.
South & Central America Cardiac Microcatheter Market Revenue and Forecast to 2028 (US$ Million)
South & Central America Cardiac Microcatheter Market Segmentation
The South & Central America cardiac microcatheter market is segmented into indication, end user, and country.
Based on indication, the South & Central America cardiac microcatheter market is segmented into general peripheral vascular and coronary. The coronary segment held a larger share of the South & Central America cardiac microcatheter market in 2023.
Based on end user, the South & Central America cardiac microcatheter market is segmented into hospitals, specialty clinics, and ambulatory surgical centers. The hospitals segment held the largest share of the South & Central America cardiac microcatheter market in 2023.
Based on country, the South & Central America cardiac microcatheter market is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the share of the South & Central America cardiac microcatheter market in 2023.
Boston Scientific Corp; Integer Holdings Corp; Medtronic Plc; Merit Medical Systems Inc; and Teleflex Inc are the leading companies operating in the South & Central America cardiac microcatheter market.